OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
Dennis Reininger, Katrin Fundel‐Clemens, Christoph H. Mayr, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 23, pp. 4766-4781
Open Access | Times Cited: 5
Dennis Reininger, Katrin Fundel‐Clemens, Christoph H. Mayr, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 23, pp. 4766-4781
Open Access | Times Cited: 5
Showing 5 citing articles:
Potential of phosphodiesterase 4B inhibition in the treatment of progressive pulmonary fibrosis
Rebecca C. Keith, Anoop M. Nambiar
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access | Times Cited: 2
Rebecca C. Keith, Anoop M. Nambiar
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access | Times Cited: 2
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access | Times Cited: 2
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access | Times Cited: 2
Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential
Wenying Lu, Alan Teoh, Maddison Waters, et al.
Pharmacology & Therapeutics (2024), pp. 108757-108757
Closed Access | Times Cited: 4
Wenying Lu, Alan Teoh, Maddison Waters, et al.
Pharmacology & Therapeutics (2024), pp. 108757-108757
Closed Access | Times Cited: 4
Design, Synthesis, and Evaluation of Selective PDE4 Inhibitors for the Therapy of Pulmonary Injury
Mengjie Li, Gang Li, Liu Y, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Mengjie Li, Gang Li, Liu Y, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Advances and future outlook in clinical trials for treating systemic sclerosis-interstitial lung disease
Marzieh Jamali, R Vázquez‐Sánchez, Prachi Agarwal, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Marzieh Jamali, R Vázquez‐Sánchez, Prachi Agarwal, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
New England Journal of Medicine (2025)
Closed Access
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
New England Journal of Medicine (2025)
Closed Access
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M. Maher, Shervin Assassi, Arata Azuma, et al.
New England Journal of Medicine (2025)
Closed Access
Toby M. Maher, Shervin Assassi, Arata Azuma, et al.
New England Journal of Medicine (2025)
Closed Access
